ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
32.49
0.36
(1.12%)
Closed January 05 3:00PM
32.7868
0.2968
(0.91%)
After Hours: 6:50PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
32.7868
Bid
29.53
Ask
33.00
Volume
195,968
32.25 Day's Range 32.59
26.03 52 Week Range 34.92
Market Cap
Previous Close
32.13
Open
32.35
Last Trade
17
@
32.77
Last Trade Time
Financial Volume
US$ 6,364,457
VWAP
32.477
Average Volume (3m)
132,670
Shares Outstanding
24,130,000
Dividend Yield
-
PE Ratio
7.55
Earnings Per Share (EPS)
4.3
Revenue
2.7M
Net Profit
103.85M

About Global X CyberSecurity ETF

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Cybersecurity Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts... The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Cybersecurity Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from increased adoption of cybersecurity technology. The fund is non-diversified. The Fund invests at least 80% of its total assets in the securities of the Indxx Cybersecurity Index (Underlying Index) and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the Underlying Index. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Wilmington, Delaware, USA
Founded
-
Global X CyberSecurity ETF is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker BUG. The last closing price for Global X CyberSecurity ETF was US$32.13. Over the last year, Global X CyberSecurity ETF shares have traded in a share price range of US$ 26.03 to US$ 34.92.

Global X CyberSecurity ETF currently has 24,130,000 shares outstanding. The market capitalization of Global X CyberSecurity ETF is US$775.30 million. Global X CyberSecurity ETF has a price to earnings ratio (PE ratio) of 7.55.

BUG Latest News

Global X ETFs Continues European Growth with the Launch of an Additional Seven Thematic UCITS ETFs

LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Global X ETFs, a leading global provider of Exchange-Traded Funds (ETFs), today announces the expansion of its European business with the addition of...

Global X Expands Roster of Thematic ETFs with Two Disruptive Tech Offerings and a Fund-of-Funds Thematic Solution

New York, NY, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today launched three new funds: the Global X Video Games & Esports...

Global X Expands Roster of Thematic ETFs with Two Disruptive Tech Offerings and a Fund-of-Funds Thematic Solution

New York, NY, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today launched three new funds: the Global X Video Games & Esports...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00680.020744356314832.7832.786831.7813228732.21318267SP
4-1.4232-4.160187079834.2134.9231.7812652433.13190146SP
120.75682.3627848891732.0334.9230.26513267032.85438367SP
263.166810.69142471329.6234.9226.0315019430.93418799SP
524.556816.141693234128.2334.9226.0317835430.05252223SP
1560.88682.7799373040831.934.9219.5825754926.46430825SP
26015.976895.043426531816.8135.09911.0223177727.41818951SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DIAMStar Diamond Corporation
$ 0.025
(25.00%)
17.1k
CSCICOSCIENS Biopharma Inc
$ 4.80
(22.14%)
11.2k
DII.BDorel Industries Inc
$ 4.88
(20.49%)
33.64k
ORVOrvana Minerals Corp
$ 0.28
(16.67%)
104.72k
YRBYorbeau Resources Inc
$ 0.04
(14.29%)
671k
FLNTFlint Corporation
$ 0.025
(-16.67%)
17k
RTGRTG Mining Inc
$ 0.03
(-14.29%)
544.49k
TWMTidewater Midstream and Infrastructure Ltd
$ 0.15
(-11.76%)
541.46k
EXROExro Technologies Inc
$ 0.13
(-10.34%)
676.19k
ASTLAlgoma Steel Group Inc
$ 12.92
(-7.58%)
196.97k
TDToronto Dominion Bank
$ 77.79
(1.69%)
17.95M
VRNVeren Inc
$ 7.48
(-1.32%)
6.26M
CNQCanadian Natural Resources Ltd
$ 45.61
(0.95%)
4.64M
ACAir Canada
$ 22.31
(-0.13%)
3.84M
BBBlackBerry Limited
$ 5.34
(-3.09%)
3.79M

Discussion

View Full Feed
sand sand 6 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 6 minutes ago
Moving hard soon 
EFSH
mining101 mining101 8 minutes ago
Superb
MEGL
benz280c benz280c 15 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 21 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 22 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 25 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 31 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 31 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 36 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 39 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 39 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 42 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 44 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 47 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 48 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 49 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 50 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 52 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 1 hour ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hour ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 1 hour ago
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 1 hour ago
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX